Alzheimer's disease and 5-HTTLPR polymorphism of the serotonin transporter gene: no evidence for an association

Am J Med Genet. 2000 Jun 12;96(3):307-9. doi: 10.1002/1096-8628(20000612)96:3<307::aid-ajmg14>3.0.co;2-0.

Abstract

Recently two independent research groups consistently reported a significant association between the serotonin transporter (5-HTT) gene and late-onset sporadic Alzheimer's disease (AD). They found that the "short" allele of the 5-HTT gene-linked polymorphic region (5-HTTLPR), which is associated with reduced transcriptional activity of the gene, increases the risk of developing late-onset AD. The present study tried to replicate this finding in a Japanese sample. We genotyped 41 patients with early-onset AD (<65 years), 82 with late-onset AD, and 336 controls. There was no significant difference in genotype or allele distribution between either patient group and controls in our sample, suggesting that the 5-HTTLPR does not play a major role in the pathogenesis of AD in Japanese.

MeSH terms

  • Age of Onset
  • Aged
  • Alleles
  • Alzheimer Disease / enzymology*
  • Alzheimer Disease / genetics*
  • Carrier Proteins / genetics*
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Japan
  • Male
  • Membrane Glycoproteins / genetics*
  • Membrane Transport Proteins*
  • Middle Aged
  • Nerve Tissue Proteins*
  • Polymorphism, Genetic
  • Serotonin / genetics*
  • Serotonin / metabolism
  • Serotonin Plasma Membrane Transport Proteins

Substances

  • Carrier Proteins
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • SLC6A4 protein, human
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin